Jiang et al. revealed that EVs secreted by RCC cell line OS-RC-2 could inhibit hepaCAM expression, a tumor suppressor frequently lost in various types of human cancers, and promote cell proliferation in a p-AKT-dependent pathway (65). The gene discussed is AKT1; the disease is renal cell carcinoma.